$1250 | Single User
$2500 | Site License
$4000 | Enterprise License

Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator -Pipeline Insights, 2017 [Report Updated: 01-09-2017]

Published by Delve Insight: 01 Sep 2017 | 117713 | In Stock

Introduction

DelveInsight’s, “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

• The report provides a snapshot of the pipeline development for the Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information

• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

• The report also covers the dormant and discontinued pipeline projects related to the Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

Reasons to Buy

• Establish comprehensive understanding of the pipeline activity across this Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator to formulate effective R&D strategies

• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator therapeutics

• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Table of Contents
for Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator -Pipeline Insights, 2017 [Report Updated: 01-09-2017]

  • 1. Report Introduction

    2. Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator Overview

    3. Pipeline Therapeutics

    • An Overview of Pipeline Products for Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

    4. Comparative Analysis

    5. Products in Clinical Stage

    5.1 Drug Name : Company Name

    • Product Description

    • Research and Development

    • Product Development Activities

    6. Products in Pre-Clinical and Discovery Stage

    6.1 Drug Name : Company Name

    • Product Description

    • Research and Development

    • Product Development Activities

    7. Therapeutic Assessment

    • Assessment by Route of Administration

    • Assessment by Stage and Route of Administration

    • Assessment by Molecule Type

    • Assessment by Stage and Molecule Type

    8. Inactive Products

    8.1 Drug Name : Company Name

    • Product Description

    • Research and Development

    • Product Development Activities

    Appendix

    Report Methodology

    Consulting Services

    Disclaimer

    About DelveInsight

List Of Tables
in Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator -Pipeline Insights, 2017 [Report Updated: 01-09-2017]

Table 1:Total Products for Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

Table 2: Products in Clinical Stage

Table 3: Products in Pre-Clinical and Discovery Stage

Table 4: Assessment by Route of Administration

Table 5: Assessment by Stage and Route of Administration

Table 6: Assessment by Molecule Type

Table 7: Assessment by Stage and Molecule Type

Table 8: Inactive Products

List Of Figures, Charts and Diagrams
in Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator -Pipeline Insights, 2017 [Report Updated: 01-09-2017]

Figure 1:Total Products for Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator

Figure 2: Products in Clinical Stage

Figure 3: Products in Pre-Clinical and Discovery Stage

Figure 4: Assessment by Route of Administration

Figure 5: Assessment by Stage and Route of Administration

Figure 6: Assessment by Molecule Type

Figure 7: Assessment by Stage and Molecule Type

Figure 8: Inactive Products

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

117713 | DIMA0065

Number of Pages

60

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2017
DelveInsight’s, “Angiotensin Converting Enzyme (ACE) Inhibitors-Pipeline Insights, 2017”, report pro...
30 May 2017 by Delve Insight USD $1,250 More Info
Angiotensin II Receptor Inhibitors -Pipeline Insights, 2017
DelveInsight’s, “Angiotensin II Receptor Inhibitors-Pipeline Insights, 2017”, report provides in dep...
30 May 2017 by Delve Insight USD $1,250 More Info
Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors -Pipeline Insights, 2017
DelveInsight’s, “Angiotensin II Receptor Type 1 (AT1 Receptor) Inhibitors-Pipeline Insights, 2017”, ...
30 May 2017 by Delve Insight USD $1,250 More Info
Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists -Pipeline Insights, 2017
DelveInsight’s, “Angiotensin II Receptor Type 2 (AT2 Receptor) Agonists-Pipeline Insights, 2017”, re...
30 May 2017 by Delve Insight USD $1,250 More Info
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitors -Pipeline Insights, 2017
DelveInsight’s, “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitors-Pipeline Insights, 2017”, ...
30 May 2017 by Delve Insight USD $1,250 More Info
Proteinuria Treatment Market: By Type (Angiotensin Converting Enzyme (ACE) Inhibitors, Aldosterone Antagonist (i.e., spironolactone), Angiotensin Receptor Blocker (ARB), and Others) & By Region-Forecast (2016-2021)
Proteinuria is a result of an excess of serum proteins in the urine, which can led to renal damage. ...
16 Aug 2016 by Industry ARC USD $5,250 More Info
Dilated Cardiomyopathy Treatment Market: By Treatment Type (Drugs - Beta blockers, Diuretics, Digitalis, Angiotensin II receptor blocker (ARBs), Angiotensin-converting enzyme inhibitors (ACE inhibitors) & Implantable devices - Heart pumps, Cardioverter-defibrillators (ICDs) & Biventricular pacemakers) & By Region-Forecast (2016-2021)
Dilated Cardiomyopathy (DCM) is a condition in which heart's left ventricle, is enlarged and weakene...
11 Mar 2016 by Industry ARC USD $5,250 More Info
Anti-Hypertensive Drugs Market: By Drugs Type (Diuretics, Calcium channel blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor antagonists, Beta-adrenoceptor antagonists) & Geography-Forecast (2016-2021)
Hypertension (HTN or HT) is a long term medical condition when blood flows through the blood vessels...
24 Feb 2016 by Industry ARC USD $5,250 More Info
Fatty Liver Treatment Market: By Drug (Thiazolidinedione, Vitamin E, Metformin Statins, Polyunsaturated fatty acids, Angiotensin receptor blockers and Pentoxifylline), By End-Use (Hospitals and Clinics) & By Region-Forecast (2016-2021)
Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulat...
23 Feb 2016 by Industry ARC USD $5,250 More Info
Antihypertensive Drugs Market Analysis: By Type (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, ARBs, Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors); – With Forecast (2016-2021)
Hypertension is a medical condition in which the blood pressure of an individual is elevated to a le...
27 Jan 2016 by Industry ARC USD $5,250 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator -Pipeline Insights, 2017 [Report Updated: 01-09-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data